Profile of suvorexant in the management of insomnia
Eliza L Sutton Department of Medicine, University of Washington, Seattle, WA, USA Abstract: Suvorexant, approved in late 2014 in the United States and Japan for the treatment of insomnia characterized by difficulty achieving and/or maintaining sleep, is a dual orexin receptor antagonist and the fi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-11-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | https://www.dovepress.com/profile-of-suvorexant-in-the-management-of-insomnia-peer-reviewed-article-DDDT |